F124 Practice Management: Vision, Execution, and Optimization
DESCRIPTION
In this session attendees will learn about essential skills that will enable them to thrive in practice. This session will include discussions around effective management of practice culture, incorporating teledermatology into a practice, and how to create and promote a diverse practice. There will also be a discussion regarding essential components of documentation in order to build and maintain a thriving practice. The session will also include time for audience members to pose their own questions to speakers regarding practice management.
LEARNING OBJECTIVES
Effectively and critically evaluate and modify your practice culture.
Utilize tested tools and methods to integrate telemedicine into practice.
Identify the essential components needed for effective documentation.
SCHEDULE
3:30 PM
Introduction
Alexandra Flamm, MD, FAAD
3:35 PM
Cultivating and Maintaining Positive Workplace Culture
Robert T Brodell, MD, FAAD
4:00 PM
Effective Coding and Documentation
Ryan Walter Hick, MD, FAAD
4:25 PM
Incorporating Teledermatology into Practice
Jules Lipoff, MD, FAAD
4:50 PM
Creating and Promoting a Diverse Practice
Lauren Claire Hollins, MD, FAAD
5:15 PM
Q&A
DIRECTOR
Alexandra Flamm, MD, FAAD
SPEAKERS
Robert T Brodell, MD, FAAD
Ryan Walter Hick, MD, FAAD
Lauren Claire Hollins, MD, FAAD
Jules Lipoff, MD, FAAD
HANDOUTS
DISCLOSURES
Robert T Brodell, MD, FAAD
Amgen – Consultant (1099 relationship)(Honoraria); Corevitas – Investigator(Grants/Research Funding); Eli Lilly – Investigator(Grants/Research Funding); Novartis Pharmaceuticals Corp. – Investigator(Grants/Research Funding); Regeneron – Consultant (1099 relationship)(Honoraria); Sanofi – Investigator(Grants/Research Funding); VeraDermics Inc. – Stockholder(Stock);
Alexandra Flamm, MD, FAAD
No financial relationships exist with ineligible companies.
Ryan Walter Hick, MD, FAAD
PP Capital – Stockholder(No Compensation Received); Sonic Healthcare – Stockholder(No Compensation Received); Stingray Therapeutics – Stockholder(No Compensation Received);
Lauren Claire Hollins, MD, FAAD
Arcutis Biotherapeutics – Advisory Board(Honoraria); Eli Lilly – Advisory Board(Honoraria); Elsevier Inc. – Other(Fees); Olaplex – Advisory Board(Fees); Pennsylvania Dermatology Physican Assistants – Speaker(Honoraria); Regeneron Pharmaceuticals, Inc. – Speaker(Fees); Sanofi Speaker Programs – Speaker(Fees);
Jules Lipoff, MD, FAAD
Amgen – Consultant (1099 relationship)(Fees); Guidepoint Global, LLC – Consultant(Fees); Pfizer Inc. – Investigator(Grants/Research Funding); Springer Science & Business Media – Other(Patent royalties or other compensation for Intellectual Property Rights); Takeda Pharmaceuticals USA Inc – Advisory Board(Fees); UpToDate – Other(Other Financial Benefit);